PUBLIC TALKS
12/2019 Invited Speaker at the Duke University in Singapore “Genomics and Immune Interactions in Head and Neck Cancer”
12/2019 Invited Speaker for the International Congress of Cancer & Clinical Oncology (CCCO-2019) (Singapore) “Genomics and Immune infiltrates in Head and Neck Cancer”
06/2019 Invited Speaker for SBS/CUHK-RENJI CSCRC/SJTU Symposium on Stem Cell and cancer research “Druggable Genomic Landscape of Head and Neck cancer”
​
05/2019 Invited Speaker for the SBS Research Day 2019, CUHK “Translational genomic landscape of head and neck cancers”
03/2019 Invited Speaker to Departmental Seminar of the Department of Chemical Pathology, CUHK “Pathway to “Precise” Head and Neck Cancer Drugging“
02/2019 Invitation by Prof. Yu Jun: “Identification of druggable mutations in cancer: What have we learnt so far?” (Feb 22, 2019); SKL research meeting, CUHK
Invited as speaker of the title topic: “Drugging Head and Neck Cancer: Don’t Forget about the Stroma on top of the Genome”
01/2019 Invited Speaker for the Nasopharyngeal Cancer Workshop in Singapore supported by the HEAD Foundation.Translational Genomics Landscape in NPC”
12/2018 Keynote Speaker for the CUHK ENT Conference 2018, HK on “Developing precision medicine and targeted therapies for Head and Neck Cancer?”
11/2018 Keynote Speaker by CUHK Medical Students (Virtual Research Lab) on Precision Medicine (November 20, 2018)
11/2018 Invited Speaker “Head and neck cancer genomics leading to rational drugging” for the Cancer 2018 Conference CUHK “Research Advances in Translational Oncology”
11/2018 Invited Speaker for The Cancer Seminar organized by ThermoFisher Scientific Hong Kong Limited, Hong Kong. "Pharmacogenomic discovery for cancer therapy: Our experiences from exome to translation”
07/2018 Invited Speaker at the Augusta University Cancer Centre, USA “Head and Neck cancers of the East and the West: our drugging opportunities”
07/2018 Keynote Speaker for “the Pathways to Success” at the Augusta University Cancer Centre faculties, USA
06/2018 Invited Speaker: the 5th International Expert Advisor meeting of NPC-TRS Project, HK “NPC Genomics”
06/2018 Poster Presenter at the Gordon Research Conference on Nasopharyngeal Carcinoma held at the HKUST, HK; poster entitled “Re-analysis of Whole-exome Sequencing Data of EBV(+) NPC and HPV(+) HNSCC Reveals Genomic Commonalities in Major Patient Subsets”
04/2018 Invited Speaker: Special Seminar, School of Pharmacy, University of Pittsburgh School of Medicine, USA. “Head and Neck Cancers of the East and West: Differences and Opportunities for Drugging?”
12/2017 Invited Speaker: in RTHK Radio Interview, HK on “Ovarian Cancer Pharmacogenomics (Mutation – drug matching)”
09/2017 Invited Speaker: Toward Precision Medicine in Head and Neck Cancers Genomics organized by HKSCO and Department of Oncology, PWH, Hong Kong
“Advances in Head and Neck Cancer Management Cross-talk between Oncologists & Surgeons”
05/2017 Invited Speaker: Cancer 2017 Conference, CUHK. “Clinically Relevant Omics of Head and Neck Cancer: Are we digging deep enough?”
05/2017 Invited Speaker: Annual Retreat of the School of Biomedical Sciences, Faculty of Medicine, CUHK. “Whole-exome Sequencing of Head and Neck Cancers and NEXT”
01/2016 Invited Speaker: Hong Kong Pharmacy Conference 2016. “Next Generation Sequencing to help Drug choice”
2015: “Genetic Drivers: Challenges and Opportunities”
Invited Speaker: The Croucher Foundation Advanced Study Institute (ASI) on Advances in Nasopharyngeal Carcinoma Studies.
10/2015 Invited Speaker: Department of Bioscience Technology, Center for Nanotechnology, Center of Biomedical Technology, Chung Yuan Christian University, Taiwan.
“From Drivers to Mechanisms in Head and Neck Cancer”
​
09/2015 Invited Speaker: School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong.
“From Drivers to Mechanisms in Head and Neck Cancer”
​
01/2015 Invited Keynote Speaker: How to translate the head and neck cancer genome into action?
Chang Gung Molecular Medicine Research Center, Chang Gung University, Taiwan.
​
11/2014 Invited Keynote Speaker: Hong Kong Pharmacology Society, at CUHK, Hong Kong.
“Head and Neck cancer genome guided PI3K targeted therapy”
11/2014 Invited Speaker: 21stHong Kong International Cancer Congress (21 Nov, 2014)“PI3K in the head and neck cancer genome”
​
11/2014 Invited Speaker: The Croucher Foundation Advanced Study Institute (ASI) on Advances in Nasopharyngeal Carcinoma Studies.
“Emerging Nasopharyngeal cancer genomics versus Head and Neck cancer genomics”
2013 Selected Oral Presentation, Mini-symposium at the American Association for Cancer Research Annual Conference, Washington DC, USA
“Whole Exome Sequencing Links MAPK1 Mutation to Exquisite Sensitivity to Brief Erlotinib Monotherapy in Head and Neck Cancer.”
​
08/2012 Invited Speaker for the HPV Mini-Symposium (Aug, 2012, University of Pittsburgh) on “Harnessing the PI3K Pathway for HNSCC Therapy”
​
07/2011 NCI Meeting:“Towards Personalized Medicine in Head and Neck Cancer: Creation of a Mutation-Drug Database” NCI Translational Science Meeting 2011: From Molecular Information to Cancer Medicine, July 28-29, 2011, Washington, DC)
​
04/2011 “ Individualized Therapy for Nasopharyngeal Cancer-How far are we? ”
Head and Neck SPORE Meeting, USA
​
04/2010 Invited Lecture to pre-doctoral and post-doctoral students and professors at the School of Pharmacy, the Chinese University of Hong Kong
“ Molecular Therapies for Cancer: Past and the Future”
​
03/2010 Lecture to MSc students in Biochemistry (part-time MSc program)
“Molecular Therapeutics”
​
03/2009 Lecture to MSc students in Biochemistry (part-time MSc program)
“Molecular Therapeutics”
​
02/2009 Lecture to the post-doctoral students and professors at the Department of Chemical Pathology, The Chinese University of Hong Kong
“Reverse Phase Protein Array for Cancer Therapeutics”
​
07/2008 Lecture at the Chinese University of Hong Kong-M. D. Anderson Cancer Center Sister Institution Signing Ceremony, Mini-Symposium, The Chinese University of Hong Kong
“Targeting Signal Transduction Pathways in Nasopharyngeal Cancer (NPC)”
03/2008 Lecture to MSc students in Biochemistry (part-time MSc program)
“Molecular Therapeutics”
​
12/2007 Lecture at the Investigator’s Meeting 2007 Biomedical Sciences, Major Area of Strategic Development, the Chinese University of Hong Kong.
“Asian Cancer Research”
​
11/2007 Lecture at the Cancer 2007 Symposium. The Chinese University of Hong Kong
“Receptor Tyrosine Kinase (RTK) Cross-talk in Head and Neck Cancers”
​
08/2007 Invited Lecture at Croucher Advance Study Institute, Molecular Genetics and Cell Signaling in Cancer and Cancer Metastasis: University of Hong Kong.
“Active c-Met signaling contributes to enhanced metastatic potential of Nasopharyngeal carcinoma (NPC)”
​
06/2007 Lecture at the State Key Laboratory of Oncology in South China, Retreat 2007, The Chinese University of Hong Kong.
“Receptor Tyrosine Kinase (RTK) Signaling and Therapeutic Opportunities”
​
05/2007 Lecture to Residents, Medical Students, Physicians in Oncology Grand Round
“Receptor Tyrosine Kinase (RTK) Cross-talk in Head and Neck Cancers”
​
03/2007 Lecture to MSc students in Biochemistry (part-time MSc program)
“Molecular Therapeutics”
​
02/2007 Invited Lecture at the Symposium for the Celebration of 35th Anniversary of Department of Biochemistry & 25th Anniversary of Faculty of Medicine, The Chinese University of Hong Kong.
04/2006 Selected Oral Presentation, Mini-symposium at the American Association for Cancer Research Annual Conference, Washington DC, USA
“Activation of STAT5 contributes to tumor growth and epithelial-mesenchymal transition in head and neck cancer”
​
“A Novel Link Between c-Met and STAT3: Implication for the Treatment of Aggressive Nasopharyngeal Cancer (NPC)”